The Current Ratio of Vir Biotechnology, Inc. (VIR) is
5.54.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
5.54
|
| 2024-12-31 |
8.71
|
| 2023-12-31 |
9.05
|
| 2022-12-31 |
4.93
|
| 2021-12-31 |
4.58
|
| 2020-12-31 |
7.79
|
| 2019-12-31 |
6.81
|
| 2018-12-31 |
2.95
|
| 2017-12-31 |
15.52
|
| Ticker |
Name |
Value |
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
4.01
|
|
MGNX
|
MacroGenics Inc
|
5.10
|
|
TWST
|
Twist Bioscience Corporation
|
3.64
|
|
XNCR
|
Xencor, Inc.
|
6.25
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
INSM
|
Insmed Incorporated
|
3.83
|
|
HRTX
|
Heron Therapeutics Inc
|
2.48
|
|
AMRN
|
Amarin Corporation PLC
|
3.34
|
|
ARWR
|
Arrowhead Pharmaceuticals, Inc.
|
4.86
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
ALLK
|
Allakos LLC
|
4.81
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
SRNE
|
Sorrento Therapeutics Inc
|
0.29
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
EDIT
|
Editas Medicine, Inc.
|
3.54
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
MYGN
|
Myriad Genetics, Inc.
|
2.49
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
3.39
|
|
NTRA
|
Natera, Inc.
|
3.39
|
|
ACAD
|
Acadia Pharmaceuticals Inc.
|
3.83
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
11.46
|
|
MORF
|
Morphic Holding Inc
|
28.94
|
|
EXEL
|
Exelixis Inc
|
3.56
|
|
PTCT
|
PTC Therapeutics, Inc.
|
2.35
|
|
VCEL
|
Vericel Corporation
|
5.03
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
6.93
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
2.06
|
|
CBPO
|
China Biologic Products Holdings Inc
|
11.77
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
2.77
|
|
PGEN
|
Precigen, Inc.
|
3.09
|
|
TVTX
|
Travere Therapeutics, Inc.
|
2.74
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
ORGO
|
Organogenesis Holdings Inc.
|
3.62
|
|
SRRK
|
Scholar Rock Holding Corporation
|
6.95
|